Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haiqiong Zheng

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Science China. Life Sciences|February 2, 2026
Strategies and mechanisms for the enhancement of chimeric antigen receptor T-cell functionsShi Han, Juan Yue, Haiqiong Zheng, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 18, 2021
Cardiac ankyrin repeat protein contributes to dilated cardiomyopathy and heart failureNa Zhang, Feiming Ye, Yu Zhou, et al.
Bone Marrow Transplantation|February 21, 2025
Clinical characteristics and outcomes of BCMA-targeted CAR-T cell recipients with COVID-19 during the Omicron wave: a retrospective studyHaiqiong Zheng, Shi Han, Yijin Chen, et al.
Experimental Hematology & Oncology|November 28, 2024
Chimeric antigen receptor-T cell therapy for T cell-derived hematological malignanciesHaiqiong Zheng, Houli Zhao, Shi Han, et al.
Blood Cancer Discovery|July 8, 2026
Genetic Mutation and Epigenetic Silencing Drive Antigen-Negative Relapse in CD7 CAR-T Treated T-cell Lymphoid MalignanciesRongrong Chen, Haiqiong Zheng, Wenxin Wang, et al.
Cell Regeneration (London, England)|September 1, 2023
Generating hematopoietic cells from human pluripotent stem cells: approaches, progress and challengesHaiqiong Zheng, Yijin Chen, Qian Luo, et al.
Circulation Research|July 9, 2021
Loss of Hepatic Angiotensinogen Attenuates Sepsis-Induced Myocardial DysfunctionJiabing Rong, Xinran Tao, Yao Lin, et al.
Bone Marrow Transplantation|March 31, 2023
HBV reactivation in patients with chronic or resolved HBV infection following BCMA-targeted CAR-T cell therapyShan Fu, Qiqi Zhang, Ruirui Jing, et al.
HLA|May 15, 2026
CD19/BCMA-Targeted Chimeric Antigen Receptor-T Cell Therapy for Anti-HLA Antibody Sensitisation in Patients With Acute Leukaemia: A Pilot Clinical StudyHaiqiong Zheng, Houli Zhao, Xinyi Zhu, et al.
Leukemia|July 3, 2026
CD7 chimeric antigen receptor T cells in patients with relapsed or refractory CD7-positive acute myeloid leukemiaMingming Zhang, Lianxuan Liu, Shan Fu, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Science China. Life Sciences|February 2, 2026
Strategies and mechanisms for the enhancement of chimeric antigen receptor T-cell functionsShi Han, Juan Yue, Haiqiong Zheng, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 18, 2021
Cardiac ankyrin repeat protein contributes to dilated cardiomyopathy and heart failureNa Zhang, Feiming Ye, Yu Zhou, et al.
Bone Marrow Transplantation|February 21, 2025
Clinical characteristics and outcomes of BCMA-targeted CAR-T cell recipients with COVID-19 during the Omicron wave: a retrospective studyHaiqiong Zheng, Shi Han, Yijin Chen, et al.
Experimental Hematology & Oncology|November 28, 2024
Chimeric antigen receptor-T cell therapy for T cell-derived hematological malignanciesHaiqiong Zheng, Houli Zhao, Shi Han, et al.
Blood Cancer Discovery|July 8, 2026
Genetic Mutation and Epigenetic Silencing Drive Antigen-Negative Relapse in CD7 CAR-T Treated T-cell Lymphoid MalignanciesRongrong Chen, Haiqiong Zheng, Wenxin Wang, et al.
Cell Regeneration (London, England)|September 1, 2023
Generating hematopoietic cells from human pluripotent stem cells: approaches, progress and challengesHaiqiong Zheng, Yijin Chen, Qian Luo, et al.
Circulation Research|July 9, 2021
Loss of Hepatic Angiotensinogen Attenuates Sepsis-Induced Myocardial DysfunctionJiabing Rong, Xinran Tao, Yao Lin, et al.
Bone Marrow Transplantation|March 31, 2023
HBV reactivation in patients with chronic or resolved HBV infection following BCMA-targeted CAR-T cell therapyShan Fu, Qiqi Zhang, Ruirui Jing, et al.
HLA|May 15, 2026
CD19/BCMA-Targeted Chimeric Antigen Receptor-T Cell Therapy for Anti-HLA Antibody Sensitisation in Patients With Acute Leukaemia: A Pilot Clinical StudyHaiqiong Zheng, Houli Zhao, Xinyi Zhu, et al.
Leukemia|July 3, 2026
CD7 chimeric antigen receptor T cells in patients with relapsed or refractory CD7-positive acute myeloid leukemiaMingming Zhang, Lianxuan Liu, Shan Fu, et al.
Pageof 2